Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
2020 · Signal Transduction and Targeted Therapy · 1,968 citations
https://doi.org/10.1038/s41392-020-00312-6
H
Huiyuan Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
361
Papers
10.3K
Citations
46
h-index
131
i10-index
Huiyuan Zhang is an academic researcher from Changchun University of Science and Technology. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cytokine Signaling Pathways and Interactions & Immune Cell Function and Interaction. The author has an h-index of 46, co-authored 307 publications.
ORCID: 0000-0002-1532-2462Papers by this author
worksGenomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design
2019 · Cell Reports · 160 citations
https://doi.org/10.1016/j.celrep.2019.09.071
5-HTR3 and 5-HTR4 located on the mitochondrial membrane and functionally regulated mitochondrial functions
2016 · Scientific Reports · 64 citations
https://doi.org/10.1038/srep37336
Novel ALK inhibitor AZD3463 inhibits neuroblastoma growth by overcoming crizotinib resistance and inducing apoptosis
2016 · Scientific Reports · 51 citations
https://doi.org/10.1038/srep19423
Amplification and over‐expression of <i><scp>MAP3K3</scp></i> gene in human breast cancer promotes formation and survival of breast cancer cells
2013 · The Journal of Pathology · 35 citations
https://doi.org/10.1002/path.4283
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
2016 · Scientific Reports · 35 citations
https://doi.org/10.1038/srep32737
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat